title: Herpes zoster: a potential risk associated with fingolimod treatment.
authors.affiliation: Department of Dermatology, La Paz University Hospital, Madrid, Spain.
authors.forename: Ander
authors.initials: A
authors.lastname: Mayor Ibarguren
authors.affiliation: Department of Dermatology, La Paz University Hospital, Madrid, Spain.
authors.forename: Cristina
authors.initials: C
authors.lastname: Gómez Fernández
authors.affiliation: Department of Neurology, La Paz University Hospital, Madrid, Spain.
authors.forename: Antonio
authors.initials: A
authors.lastname: Tallón Barranco
authors.affiliation: Department of Neurology, La Paz University Hospital, Madrid, Spain.
authors.forename: Mireya
authors.initials: M
authors.lastname: Fernández Fournier
authors.affiliation: Department of Dermatology, La Paz University Hospital, Madrid, Spain.
authors.forename: Jéssica
authors.initials: J
authors.lastname: González Ramos
authors.affiliation: Department of Microbiology, La Paz University Hospital, Madrid, Spain.
authors.forename: María P
authors.initials: MP
authors.lastname: Romero Gómez
authors.affiliation: Department of Dermatology, La Paz University Hospital, Madrid, Spain.
authors.forename: Pedro
authors.initials: P
authors.lastname: Herranz Pinto
mesh_terms: D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D000068876:Fingolimod Hydrochloride / Q000009:adverse effects* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006562:Herpes Zoster / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D012008:Recurrence; D018570:Risk Assessment; D016896:Treatment Outcome; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir